Blogs
Stay Informed: QPharma News, Events, and Insights
Our Blogs

Why Do Some Hospitals Reject Pharmaceutical Samples?
Pharmaceutical samples have long been a recognized part of the healthcare landscape: providing patients with immediate access to therapy and

From Sales-Led to Orchestrated Omnichannel Engagement: Turning Strategy into Execution
As pharmaceutical commercial organizations continue to evolve, omnichannel engagement has moved from aspiration to expectation. Most companies have defined their

Enhancing eLearning with AI Narration: Scalable, High-Quality Training for Modern Learners
As eLearning evolves, organizations need faster, more flexible ways to create training without compromising quality. AI-powered narration has emerged as

CMS Open Payments Review Period – Managing Disputes and Late Submissions
Each year, the CMS Open Payments review and dispute period, April 1st through May 15th, places pressure on pharmaceutical manufacturers

When Poor Vendor Performance Becomes a Business Risk: Why It May Be Time to Make a Change
Pharmaceutical companies rely on a wide network of external vendors to support critical functions across commercial, regulatory, and operational areas.

Sales Representative Registration Isn’t Optional: What Miami-Dade Teaches Pharma About Lobbyist Compliance
Imagine losing access to a major Southeast public health system because your field representatives weren’t properly registered. For pharmaceutical manufacturers,

How Digital Sampling Is Transforming HCP Engagement at Medical Congresses
Medical congresses create powerful moments of HCP interest, but too often, that momentum is lost. Explore how digital sampling is

From Insight to Impact, Part 2: Preparing for a Powerful Conference Season
The value you gain from a conference is determined long before the first keynote session begins. With the right preparation,

Validation Documentation Is Just Like Baseball, Right?
When viewed in comparison to baseball, validation becomes not just a compliance requirement, but a strategic advantage grounded in preparation

Where Big Pharma Consumer Marketing Is Headed in 2026 and Beyond
As Big Pharma accelerates into 2026 and beyond, one truth is clear: the future of consumer marketing will belong to








